The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling (Q21133611)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling |
scientific article |
Statements
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling (English)
0 references
Katherine L Nathanson
Katherine L
Nathanson
Meenhard Herlyn
Meenhard
Herlyn
Keith T Flaherty
Keith T
Flaherty
Keiran S M Smalley
Keiran S M
Smalley
Clemens Krepler
Clemens
Krepler
Jessie Villanueva
Thierry-Thien K Nguyen
Min Xiao
Jun Kong
2013
0 references
8
0 references
e59588
0 references
3
0 references
18 March 2013
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference